Advances in Targeted Immunotherapy in Cancers

Na Luo

doi:10.3390/ijms242417475

Advances in Targeted Immunotherapy in Cancers

Int J Mol Sci. 2023 Dec 14;24(24):17475. doi: 10.3390/ijms242417475.

Author

Na Luo¹

Affiliation

¹ Department of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China.

Abstract

Immunotherapy has revolutionized cancer treatment, especially the emergence of immune checkpoint inhibitors (ICIs), which has been considered as a significant breakthrough in cancer therapy [...].

Publication types

Editorial

MeSH terms

Humans
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy*
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors

Grants and funding

This research received no external funding.